Advanced search
Publication Cover
mAbs Volume 6, 2014 - Issue 5
Submit an article Journal homepage
4,178
Views
67
CrossRef citations to date
0
Altmetric
SHORT COMMUNICATION

Effect of formulation on the stability and aerosol performance of a nebulized antibody

Renaud RespaudGénétique, Immunothérapie, Chimie et Cancer; UMR 7292/EA6306; Tours, France;Université François Rabelais; EA 6306; Tours, France;CHRU Tours; Service de Pharmacie; Tours, France
,
Denis MarchandCentre d’Etude des Pathologies Respiratoires; UMR 1100/EA6305; Tours, France;Université François Rabelais; EA 6305; Tours, France;Aerodrug; DTF; Tours, France
,
Christelle ParentCentre d’Etude des Pathologies Respiratoires; UMR 1100/EA6305; Tours, France;Université François Rabelais; EA 6305; Tours, France
,
Thibaut PelatInstitut de Recherche Biomédicale des Armées (IRBA-CRSSA); Département de Microbiologie; Unité de biotechnologie des anticorps et des toxines; Brétigny sur Orge, France
,
Philippe ThullierInstitut de Recherche Biomédicale des Armées (IRBA-CRSSA); Département de Microbiologie; Unité de biotechnologie des anticorps et des toxines; Brétigny sur Orge, France
,
Jean-François TournamilleGénétique, Immunothérapie, Chimie et Cancer; UMR 7292/EA6306; Tours, France;Université François Rabelais; EA 6306; Tours, France;CHRU Tours; Service de Pharmacie; Tours, France
,
Marie-Claude Viaud-MassuardGénétique, Immunothérapie, Chimie et Cancer; UMR 7292/EA6306; Tours, France;Université François Rabelais; EA 6306; Tours, France
,
Patrice DiotCentre d’Etude des Pathologies Respiratoires; UMR 1100/EA6305; Tours, France;Université François Rabelais; EA 6305; Tours, France;CHRU Tours; Service de Pneumologie; Tours, France
,
Mustapha Si-TaharCentre d’Etude des Pathologies Respiratoires; UMR 1100/EA6305; Tours, France
,
Laurent VecellioCentre d’Etude des Pathologies Respiratoires; UMR 1100/EA6305; Tours, France;Université François Rabelais; EA 6305; Tours, France;Aerodrug; DTF; Tours, France
&
Nathalie Heuzé-Vourc’hCentre d’Etude des Pathologies Respiratoires; UMR 1100/EA6305; Tours, France;Université François Rabelais; EA 6305; Tours, FranceCorrespondence[email protected]
 show all
Pages 1347-1355 | Received 21 May 2014, Accepted 14 Jul 2014, Published online: 30 Oct 2014

Citations (67)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Maria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, Mario Cazzola & Paola Rogliani. (2023) Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases. Expert Opinion on Drug Delivery 20:8, pages 1085-1095.
Read now
Thomas Sécher & Nathalie Heuzé-Vourc’h. (2023) Barriers for orally inhaled therapeutic antibodies. Expert Opinion on Drug Delivery 20:8, pages 1071-1084.
Read now
Daniele Focosi & Fabrizio Maggi. (2023) Respiratory delivery of passive immunotherapies for SARS-CoV-2 prophylaxis and therapy. Human Vaccines & Immunotherapeutics 19:2.
Read now
Mario Cazzola, Josuel Ora, Francesco Cavalli, Paola Rogliani & Maria Gabriella Matera. (2021) An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease. Biologics: Targets and Therapy 15, pages 363-374.
Read now
Mario Cazzola, Francesco Cavalli, Omar S. Usmani & Paola Rogliani. (2020) Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Delivery 17:5, pages 635-646.
Read now
Guangcan Cao, Xinyu Gao, Yancheng Zhan, Qingguang Wang, Zhe Zhang, Dimiter S. Dimitrov & Rui Gong. (2020) An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific binding. mAbs 12:1.
Read now
Elsa Bodier-Montagutelli, Alexie Mayor, Laurent Vecellio, Renaud Respaud & Nathalie Heuzé-Vourc’h. (2018) Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?. Expert Opinion on Drug Delivery 15:8, pages 729-736.
Read now
Elsa Bodier-Montagutelli, Eric Morello, Guillaume L’Hostis, Antoine Guillon, Emilie Dalloneau, Renaud Respaud, Nikita Pallaoro, Hélène Blois, Laurent Vecellio, Jérôme Gabard & Nathalie Heuzé-Vourc’h. (2017) Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections. Expert Opinion on Drug Delivery 14:8, pages 959-972.
Read now
Elsa Bodier-Montagutelli, Renaud Respaud, Hervé Watier & Audrey Guillon-Munos. (2017) MAbDelivery: Administration routes for antibody therapy Third LabEx MAbImprove industrial workshop, July 2, 2015 Tours, France. mAbs 9:4, pages 579-585.
Read now
Guillaume Desoubeaux, Janice M. Reichert, Matthew Sleeman, Karen L. Reckamp, Bernhard Ryffel, Jörg P. Adamczewski, Theresa D. Sweeney, Rita Vanbever, Patrice Diot, Caroline A. Owen, Clive Page, Stéphanie Lerondel, Alain Le Pape & Nathalie Heuze-Vourc'h. (2016) Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France. mAbs 8:6, pages 999-1009.
Read now
Renaud Respaud, Laurent Vecellio, Patrice Diot & Nathalie Heuzé-Vourc’h. (2015) Nebulization as a delivery method for mAbs in respiratory diseases. Expert Opinion on Drug Delivery 12:6, pages 1027-1039.
Read now

Articles from other publishers (56)

Sohaib Mahri, Tobias Wilms, Paul Hagedorm, Marie-Julie Guichard, Kevin Vanvarenberg, Mireille Dumoulin, Henderik Frijlink & Rita Vanbever. (2023) Nebulization of PEGylated recombinant human deoxyribonuclease I using vibrating membrane nebulizers: A technical feasibility study. European Journal of Pharmaceutical Sciences 189, pages 106522.
Crossref
Rohan Flint, Daniel R. Laucirica, Hak-Kim Chan, Barbara J. Chang, Stephen M. Stick & Anthony Kicic. (2023) Stability Considerations for Bacteriophages in Liquid Formulations Designed for Nebulization. Cells 12:16, pages 2057.
Crossref
Emma R. Sudduth, Michael Trautmann-Rodriguez, Nicole Gill, Kartik Bomb & Catherine A. Fromen. (2023) Aerosol pulmonary immune engineering. Advanced Drug Delivery Reviews 199, pages 114831.
Crossref
Xiyue He, Xiaoyan Chen, Hairui Wang, Guangsheng Du & Xun Sun. (2023) Recent advances in respiratory immunization: A focus on COVID-19 vaccines. Journal of Controlled Release 355, pages 655-674.
Crossref
Michael Y.T. Chow, Harry W. Pan, Han Cong Seow & Jenny K.W. Lam. (2023) Inhalable neutralizing antibodies – promising approach to combating respiratory viral infections. Trends in Pharmacological Sciences 44:2, pages 85-97.
Crossref
Rami Fishler, Yan Ostrovski, Avital Frenkel, Simon Dorfman, Mordechai Vaknin, Dan Waisman, Netanel Korin & Josué Sznitman. (2023) Exploring pulmonary distribution of intratracheally instilled liquid foams in excised porcine lungs. European Journal of Pharmaceutical Sciences 181, pages 106359.
Crossref
Carlos Victor Montefusco-Pereira. (2023) Steps toward nebulization in-use studies to understand the stability of new biological entities. Drug Discovery Today 28:2, pages 103461.
Crossref
François Noverraz, Baptiste Robin, Solène Passemard, Bénédicte Fauvel, Jessy Presumey, Emilie Rigal, Alan Cookson, Joël Chopineau, Pierre Martineau, Martin Villalba, Christian Jorgensen, Anne Aubert-Pouëssel, Marie Morille & Sandrine Gerber-Lemaire. (2023) Novel trehalose-based excipients for stabilizing nebulized anti-SARS-CoV-2 antibody. International Journal of Pharmaceutics 630, pages 122463.
Crossref
Amal Ali Elkordy, Amerah Parveen & Rita Haj-Ahmad. 2023. Formulation of Monoclonal Antibody Therapies. Formulation of Monoclonal Antibody Therapies 209 258 .
Yohan Han, Yin Zhu, Hannah A. Youngblood, Sultan Almuntashiri, Timothy W. Jones, Xiaoyun Wang, Yutao Liu, Payaningal R. Somanath & Duo Zhang. (2022) Nebulization of extracellular vesicles: A promising small RNA delivery approach for lung diseases. Journal of Controlled Release 352, pages 556-569.
Crossref
Alexie Mayor, Béatrice Thibert, Sylvain Huille, Fethi Bensaid, Renaud Respaud, Héloïse Audat & Nathalie Heuzé–Vourc'h. (2022) Inhaled IgG1 antibodies: The buffering system is an important driver of stability during mesh-nebulization. European Journal of Pharmaceutics and Biopharmaceutics 181, pages 173-182.
Crossref
Lars M.H. Reinders, Dennis Noelle, Martin D. Klassen, Martin Jaeger, Torsten C. Schmidt, Jochen Tuerk & Thorsten Teutenberg. (2022) Development and validation of a method for airborne monoclonal antibodies to quantify workplace exposure. Journal of Pharmaceutical and Biomedical Analysis 221, pages 115046.
Crossref
Jilei Jia, Zhaojuan Yin, Xiao Zhang, Huimin Li, Dan Meng, Qianqian Liu, Hongfang Wang, Meng Han, Shixiang Suo, Yan Liu, Ping Hu, Chunyun Sun, Jing Li & Liangzhi Xie. (2022) Feasibility Studies of Nebulized SARS-CoV-2 Neutralizing Antibody in Mice and Cynomolgus Monkeys. Pharmaceutical Research 39:9, pages 2191-2201.
Crossref
. (2022) ISOPP Standards for the Safe Handling of Cytotoxics. Journal of Oncology Pharmacy Practice 28:3_suppl, pages S1-S126.
Crossref
Thomas Sécher, Elsa Bodier-Montagutelli, Christelle Parent, Laura Bouvart, Mélanie Cortes, Marion Ferreira, Ronan MacLoughlin, Guy Ilango, Otmar Schmid, Renaud Respaud & Nathalie Heuzé-Vourc’h. (2022) Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects. Pharmaceutics 14:3, pages 671.
Crossref
Mario Cazzola, Josuel Ora, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2022) The future of inhalation therapy in chronic obstructive pulmonary disease. Current Research in Pharmacology and Drug Discovery 3, pages 100092.
Crossref
Varsha Komalla, Mehra Haghi & Veysel Kayser. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases 493 521 .
Hilal Ahmad Parray, Shivangi Shukla, Reshma Perween, Ritika Khatri, Tripti Shrivastava, Vanshika Singh, Praveenkumar Murugavelu, Shubbir Ahmed, Sweety Samal, Chandresh Sharma, Subrata Sinha, Kalpana Luthra & Rajesh Kumar. (2021) Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections. Applied Microbiology and Biotechnology 105:16-17, pages 6315-6332.
Crossref
Yajie Zhang, Daniel A. Davis, Khaled AboulFotouh, Jieliang Wang, Donna Williams, Akhilesh Bhambhani, Michael Zakrewsky, Mohammed Maniruzzaman, Zhengrong Cui & Robert O. WilliamsIIIIII. (2021) Novel formulations and drug delivery systems to administer biological solids. Advanced Drug Delivery Reviews 172, pages 183-210.
Crossref
Carlos Cruz-Teran, Karthik Tiruthani, Morgan McSweeney, Alice Ma, Raymond Pickles & Samuel K. Lai. (2021) Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy. Advanced Drug Delivery Reviews 169, pages 100-117.
Crossref
Tomás Sou & Christel A.S. Bergström. (2021) Contemporary Formulation Development for Inhaled Pharmaceuticals. Journal of Pharmaceutical Sciences 110:1, pages 66-86.
Crossref
Samuel K. Lai, Morgan D. McSweeney & Raymond J. Pickles. (2021) Learning from past failures: Challenges with monoclonal antibody therapies for COVID-19. Journal of Controlled Release 329, pages 87-95.
Crossref
Michael Y.T. Chow, Rachel Yoon Kyung Chang & Hak-Kim Chan. (2021) Inhalation delivery technology for genome-editing of respiratory diseases. Advanced Drug Delivery Reviews 168, pages 217-228.
Crossref
Abigail A. Matthews, Pui Lai Rachel Ee & Ruowen Ge. (2020) Developing inhaled protein therapeutics for lung diseases. Molecular Biomedicine 1:1.
Crossref
Lucas Gutierrez, Nina S. Cauchon, Twinkle R. Christian, Michael J. Giffin & Michael J. Abernathy. (2020) The Confluence of Innovation in Therapeutics and Regulation: Recent CMC Considerations. Journal of Pharmaceutical Sciences 109:12, pages 3524-3534.
Crossref
Anna Maria Piras, Ylenia Zambito, Maurizio Lugli, Baldassare Ferro, Paolo Roncucci, Filippo Mori, Alfonso Salvatore, Ester Ascione, Marta Bellini & Roberto Crea. (2020) Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics. Pharmaceuticals 13:12, pages 425.
Crossref
Yu. G. Belotserkovskaya. (2020) Рossibilities of clinical application of modern nebulizers. Meditsinskiy sovet = Medical Council:17, pages 50-55.
Crossref
Veeren M. Chauhan, Hongyu Zhang, Paul A. Dalby & Jonathan W. Aylott. (2020) Advancements in the co-formulation of biologic therapeutics. Journal of Controlled Release 327, pages 397-405.
Crossref
Adam Vigil, Natalia Frias-Staheli, Teresa Carabeo & Michael Wittekind. (2020) Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Antiviral Activities and Enables Broad-Coverage Combination Therapies. Journal of Virology 94:22.
Crossref
Wanling Liang, Harry W. Pan, Driton Vllasaliu & Jenny K. W. Lam. (2020) Pulmonary Delivery of Biological Drugs. Pharmaceutics 12:11, pages 1025.
Crossref
Tomás Sou, Fadi Soukarieh, Paul Williams, Michael J. Stocks, Miguel Cámara & Christel A. S. Bergström. (2020) Model-Informed Drug Discovery and Development in Pulmonary Delivery: Biopharmaceutical Pharmacometric Modeling for Formulation Evaluation of Pulmonary Suspensions. ACS Omega 5:40, pages 25733-25746.
Crossref
Mouhamad Reslan, Vicki Sifniotis, Esteban Cruz, Zeynep Sumer-Bayraktar, Stuart CordwellProf.Prof. & Veysel Kayser. (2020) Enhancing the stability of adalimumab by engineering additional glycosylation motifs. International Journal of Biological Macromolecules 158, pages 189-196.
Crossref
Kyung Hwa Chang, Sang-Hyub Moon, Sun Kook Yoo, Bong Joo Park & Ki Chang Nam. (2020) Aerosol Delivery of Dornase Alfa Generated by Jet and Mesh Nebulizers. Pharmaceutics 12:8, pages 721.
Crossref
Elsa Bodier-Montagutelli, Renaud Respaud, Gérald Perret, Linda Baptista, Philippe Duquenne, Nathalie Heuzé-Vourc'h & Laurent Vecellio. (2020) Protein stability during nebulization: Mind the collection step!. European Journal of Pharmaceutics and Biopharmaceutics 152, pages 23-34.
Crossref
Susan Marqus, Lillian Lee, Taghrid Istivan, Rachel Yoon Kyung Chang, Chaitali Dekiwadia, Hak-Kim Chan & Leslie Y. Yeo. (2020) High frequency acoustic nebulization for pulmonary delivery of antibiotic alternatives against Staphylococcus aureus. European Journal of Pharmaceutics and Biopharmaceutics 151, pages 181-188.
Crossref
Sean D. McCarthy, Héctor E. González & Brendan D. Higgins. (2020) Future Trends in Nebulized Therapies for Pulmonary Disease. Journal of Personalized Medicine 10:2, pages 37.
Crossref
Cédric Vonarburg, Marius Loetscher, Martin O. Spycher, Alain Kropf, Marlies Illi, Sharon Salmon, Sean Roberts, Karin Steinfuehrer, Ian Campbell, Sandra Koernig, Joseph Bain, Monika Edler, Ulrich Baumann, Sylvia Miescher, Dennis W. Metzger, Alexander Schaub, Fabian Käsermann & Adrian W. Zuercher. (2019) Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates. Respiratory Research 20:1.
Crossref
Kim, Kim, Kim, Chang, Shim, Jin, Lim, Baek, Min, Park, Oh, Kim & Chung. (2019) Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody. International Journal of Molecular Sciences 20:20, pages 5073.
Crossref
Moritz Beck-Broichsitter. (2019) Making Concentrated Antibody Formulations Accessible for Vibrating-Mesh Nebulization. Journal of Pharmaceutical Sciences 108:8, pages 2588-2592.
Crossref
Thomas Sécher, Emilie Dalonneau, Marion Ferreira, Christelle Parent, Nicolas Azzopardi, Gilles Paintaud, Mustapha Si-Tahar & Nathalie Heuzé-Vourc'h. (2019) In a murine model of acute lung infection, airway administration of a therapeutic antibody confers greater protection than parenteral administration. Journal of Controlled Release 303, pages 24-33.
Crossref
Homa Faghihi, Abdolhossein Rouholamini Najafabadi, Zahra Daman, Elham Ghasemian, Hamed Montazeri & Alireza Vatanara. (2019) Respiratory Administration of Infliximab Dry Powder for Local Suppression of Inflammation. AAPS PharmSciTech 20:3.
Crossref
Tomás Sou, Irena Kukavica-Ibrulj, Fadi Soukarieh, Nigel Halliday, Roger C. Levesque, Paul Williams, Michael Stocks, Miguel Cámara, Lena E. Friberg & Christel A.S. Bergström. (2019) Model-Based Drug Development in Pulmonary Delivery: Pharmacokinetic Analysis of Novel Drug Candidates for Treatment of Pseudomonas aeruginosa Lung Infection. Journal of Pharmaceutical Sciences 108:1, pages 630-640.
Crossref
Joseph P. Cornish & Reed F. Johnson. 2019. Defense Against Biological Attacks. Defense Against Biological Attacks 195 223 .
N. Joshi. (2018) Nanotechnology Enabled Inhalation of Bio-therapeutics for Pulmonary Diseases: Design Considerations and Challenges. Current Pathobiology Reports 6:4, pages 225-231.
Crossref
Jens Kvist Madsen, Lise Giehm & Daniel E. Otzen. (2018) The Use of Surfactants to Solubilise a Glucagon Analogue. Pharmaceutical Research 35:12.
Crossref
Daniel Lightwood, Markus Tservistas, Monique Zehentleitner, Kaushik Sarkar, Alison Turner, Marguerite Bracher, Bryan Smith, Sabrina Lamour, Tim Bourne, Stevan Shaw, Neil Gozzard & Roger T. Palframan. (2018) Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic Asthma. American Journal of Respiratory and Critical Care Medicine 198:5, pages 610-619.
Crossref
Bing Yang, Alison Schaefer, Ying-Ying Wang, Justin McCallen, Phoebe Lee, Jay M Newby, Harendra Arora, Priya A Kumar, Larry Zeitlin, Kevin J Whaley, Scott A McKinley, William A FischerIIII, Dimple Harit & Samuel K Lai. (2018) ZMapp Reinforces the Airway Mucosal Barrier Against Ebola Virus. The Journal of Infectious Diseases 218:6, pages 901-910.
Crossref
Soraya Hengsawas Surasarang, Sawittree Sahakijpijarn, Galina Florova, Andrey A. Komissarov, Christina L. Nelson, Enkhbaatar Perenlei, Satoshi Fukuda, Marla R. Wolfson, Thomas H. Shaffer, Steven Idell & Robert O. WilliamsIIIIII. (2018) Nebulization of single-chain tissue-type and single-chain urokinase plasminogen activator for treatment of inhalational smoke-induced acute lung injury. Journal of Drug Delivery Science and Technology 46, pages 19-27.
Crossref
Bifeng Wang & Wolfgang Friess. (2018) Lipid-coated mannitol core microparticles for sustained release of protein. European Journal of Pharmaceutics and Biopharmaceutics 128, pages 91-97.
Crossref
Mark C. Manning, Jun Liu, Tiansheng Li & Ryan E. Holcomb. 2018. Therapeutic Proteins and Peptides. Therapeutic Proteins and Peptides 1 59 .
Martina Röhm, Stefan Carle, Frank Maigler, Johannes Flamm, Viktoria Kramer, Chrystelle Mavoungou, Otmar Schmid & Katharina Schindowski. (2017) A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery. International Journal of Pharmaceutics 532:1, pages 537-546.
Crossref
Albert Jesuran Paul, Fabian Bickel, Martina Röhm, Lisa Hospach, Bettina Halder, Nina Rettich, René Handrick, Eva Maria Herold, Hans Kiefer & Friedemann Hesse. (2017) High-throughput analysis of sub-visible mAb aggregate particles using automated fluorescence microscopy imaging. Analytical and Bioanalytical Chemistry 409:17, pages 4149-4156.
Crossref
Ferdinando Maria Milazzo, Anna Maria Anastasi, Caterina Chiapparino, Antonio Rosi, Barbara Leoni, Loredana Vesci, Fiorella Petronzelli & Rita De Santis. (2017) AvidinOX-anchored biotinylated trastuzumab and pertuzumab induce down-modulation of ErbB2 and tumor cell death at concentrations order of magnitude lower than not-anchored antibodies. Oncotarget 8:14, pages 22590-22605.
Crossref
Robert C. Fellner, Shawn T. Terryah & Robert Tarran. (2016) Inhaled protein/peptide-based therapies for respiratory disease. Molecular and Cellular Pediatrics 3:1.
Crossref
Renaud Respaud, Denis Marchand, Thibaut Pelat, Kam-Meng Tchou-Wong, Chad J. Roy, Christelle Parent, Maria Cabrera, Joël Guillemain, Ronan Mac Loughlin, Eric Levacher, Alexandre Fontayne, Laurence Douziech-Eyrolles, Alexandra Junqua-Moullet, Laurent Guilleminault, Philippe Thullier, Emmanuelle Guillot-Combe, Laurent Vecellio & Nathalie Heuzé-Vourc'h. (2016) Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin. Journal of Controlled Release 234, pages 21-32.
Crossref
Priyanka Bhatt, Imran Vhora, Sushilkumar Patil, Jitendra Amrutiya, Chandrali Bhattacharya, Ambikanandan Misra & Rajashree Mashru. (2016) Role of antibodies in diagnosis and treatment of ovarian cancer: Basic approach and clinical status. Journal of Controlled Release 226, pages 148-167.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.